News for Mycotopia Therapies Inc. (TPIA)

MIAMI, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. dba AIBotics (”œAIBotics” or the ”œCompany”) ( TPIA) and a wholly owned subsidiary of

AIBotics and DigiTrax Entertainment aim to redefine music creation and experience using Artificial Intelligence based algorithms trained in music theory, tapping into the $2.9 billion Global AI in Music market

MIAMI, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. dba AIBotics ('AIBotics' or the 'Company') (OTC: TPIA), a developer and manager of AI- and robotics-enhanced companies and technologies, today announced an outline of its growth milestones in 2024 and its strategic vision for 2025.

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review. In connection with the preparation of the Ehave, Inc. financial... | May 2, 2023

MIAMI and MAUI, Hawaii, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Ei.Ventures, Inc. (Ei.Ventures) and Mycotopia Therapies Inc. (“Mycotopia Therapies”)(OTC: TPIA)...

Medical Psychedelics have made it into Davos, just in time for the World Economic Forum.

Mycotopia Therapies (OTCPK:TPIA) subsidiary of Ehave, Inc. (OTCPK:EHVVF), has signed a definitive agreement to complete a triangular merger with Ei.Ventures, to form PSLY.COM. The companies anticipate closing the transaction on or about July 30, 2022.

Ehave owns approximately 9,793,754 shares of Mycotopia Therapies valued at more than $24 million, as of Friday’s closing price; Plans partial distribution...

/PRNewswire/ -- Ei.Ventures Inc. ("Ei") today announced an update on the previously announced merger with Mycotopia (OTC: TPIA) MERGER UPDATE Ei has executed a...

Two companies in the psychedelics space have signed a definitive agreement to merge.

Entities on track to merge under PSLY.com and list on NASDAQ Stock Exchange...